Gujarat Terce Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/02/2026 ,inter alia, to consider and approve Unaudited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Gujarat Terce Laboratories has informed BSE that its Board of Directors will meet on Wednesday, 4 February 2026 to consider and approve the Unaudited Standalone Financial Results for the third quarter and nine months ended 31 December 2025. The trading window for dealing in the company's shares will remain closed from 1 January 2026 to 6 February 2026 (both days inclusive) in line with insider trading norms. The intimation has also been uploaded on the company's website. No financial numbers, projections, or dividend announcements are included in this filing.
This is a routine procedural filing with no immediate impact on shareholders. Investors should watch the actual Q3 results announcement on or after 4 February 2026 for any material performance update.